Targeting RSK2 in human malignancies

The Coffin-Lowry syndrome. Experience from four centres

(2010) Alasdair G. W. Hunter et al.   CLINICAL GENETICS

Emerging drugs to treat squamous cell carcinomas of the head and neck

(2010) Christopher Fung et al.   EXPERT OPINION ON EMERGING DRUGS

p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells

(2010) Sumin Kang et al.   JOURNAL OF CLINICAL INVESTIGATION

Review Article: Targeted Therapy: Comprehensive Review

(2009) Ricardo Lima Barros Costa   American Journal of Hospice & Palliative Medicine

Fibroblast Growth Factor Receptor 1-Transformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival

(2009) W. Xian et al.   CANCER RESEARCH

Coffin–Lowry syndrome

(2009) Patricia Marques Pereira et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation

(2009) S. Kang et al.   MOLECULAR AND CELLULAR BIOLOGY

RSK Is a Principal Effector of the RAS-ERK Pathway for Eliciting a Coordinate Promotile/Invasive Gene Program and Phenotype in Epithelial Cells

(2009) Ulrik Doehn et al.   MOLECULAR CELL

βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis

(2009) Elinor Dehan et al.   MOLECULAR CELL

The RSK factors of activating the Ras/MAPK signaling cascade

(2008) Audrey Carriere   Frontiers in Bioscience-Landmark

Codependent Functions of RSK2 and the Apoptosis-Promoting Factor TIA-1 in Stress Granule Assembly and Cell Survival

(2008) T.S. Karin Eisinger-Mathason et al.   MOLECULAR CELL

The RSK family of kinases: emerging roles in cellular signalling

(2008) Rana Anjum et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY